跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-DEXTROAMPHETAMINE SR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-DEXTROAMPHETAMINE SR
Authorized
STANDARD
TEVA-DEXTROAMPHETAMINE SR
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0079874e86ec7b24
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
0079874e86ec7b24
Drug Approval Canada Name
TEVA-DEXTROAMPHETAMINE SR
Product Name
TEVA-DEXTROAMPHETAMINE SR
Status
Marketed
Status Date
2024-04-12
Original Market Date
2017-10-06
Din
02448327
Drug Class
Human
Dosage Form
Capsule (Sustained-Release)
Route Of Administration
Oral
Schedule
Schedule G (CDSA I)
Ahfs
28:20.04
Atc Original
N06BA02 DEXAMFETAMINE
Atc Name
n 06 ba 02
Aig Number
0105933001
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
DEXTROAMPHETAMINE SULFATE
15 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0079874e86ec7b24
Type
Standard
Back to Health Canada Approvals